Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Breast Cancer Clinical Advisory Board
    • Cancer Business Advisory Board
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
      • Breast Cancer Clinical Advisory Board
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Invest in the Future of Cancer Immunotherapy & Women’s Health
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
    • YouTube Channel
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • News Releases
  • Invest in the Future of Cancer Immunotherapy & Women’s Health
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Fact Sheet
    • Contact IR
    • RSS News Feed
  • All News
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

ITUS Presentation to Annual Meeting of Stockholders

September 26, 2017

ITUS Corporation to Present at the 2017 Disruptive Growth Company Showcase NYC Presented by SeeThruEquity and RHK Capital

September 25, 2017

ITUS Provides Update on Cancer Detection Technology and New CAR-T Initiative for Ovarian Cancer

September 21, 2017

ITUS Corporation Announces Issuance of Patent on Cancer Detection Technology

September 18, 2017

The Wistar Institute and ITUS Corporation Renew Collaborative Research Agreement

August 7, 2017

Lew Titterton re-joins ITUS Corporation's Board of Directors

July 18, 2017

ITUS Appoints Dr. Amit Kumar as New CEO and Announces Management Changes

July 7, 2017

ITUS Corporation to Present at the 7th Annual LD Micro Conference

June 1, 2017

ITUS Corporation to Present at WallStreet Research Hosted Event on May 31 in Los Angeles

May 30, 2017

ITUS Corporation Successfully Completes $3.6 Million Public Offering

May 16, 2017

RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • Next »

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Jun 23, 2025

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Read More...
Jun 20, 2025

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Read More...
Jun 10, 2025

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

Read More...
Copyrights © 2025 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Terms of Use Disclaimer Sitemap